Modulation of Host Cell Exosome Content and Function by EBV LMP1

EBV LMP1 对宿主细胞外泌体含量和功能的调节

基本信息

  • 批准号:
    9896794
  • 负责人:
  • 金额:
    $ 40.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-04-01 至 2022-03-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Exosomes are small vesicles released at high levels from cancer cells that are important modifiers of the tumor environment and contribute to disease progression. Exosomes contain molecular information about their cells of origin and can be isolated from many biological fluids including blood, urine, and saliva. It has recently been discovered that exosomes from breast cancer cells or the blood of patients with the disease can cause non- cancerous cells to form tumors. These findings suggest a critical role of exosomes in cancer development or disease progression, and create new opportunities for exosome-based diagnostics and therapies. Based on data from our studies and others, it is also becoming clear that cancer causing viruses utilize and modify the host cell exosome pathway, and these changes may contribute to disease. For example, cells infected with the Epstein-Barr virus (EBV), a human tumor virus, release exosomes that are enriched in viral products like the major viral oncogene latent membrane protein 1 (LMP1) and virally-encoded miRNAs. We have previously shown that LMP1 alters the cargo of exosomes released from infected cells and that these LMP1-modifed exosomes can exert oncogenic signaling functions on neighboring uninfected cells. In spite of the importance of inter-cellular transmission of LMP1-modifeid exosomes, very little is known about how this viral protein actually enters and manipulates the host exosome pathway. The overall goal of these studies is to determine the mechanisms that LMP1 drives exosome content reorganization and alters the functions of exosomes. We hypothesize that LMP1 exosomal trafficking modulates the components and biological properties of exosomes by altering endocytic routes and membrane microdomains. To test this, we aim to: 1.) investigate the mechanism through which LMP1 alters exosome components; 2.) determine the functions of LMP1-modified exosomes in intracellular communication and cellular transformation.
 描述(由申请人提供):外泌体是癌细胞高水平释放的小囊泡,是肿瘤环境的重要调节剂并有助于疾病进展。外泌体含有有关其来源细胞的分子信息,可以从许多生物液体中分离出来,包括血液、尿液和唾液。最近发现,来自乳腺癌细胞或乳腺癌患者血液的外泌体可以导致非癌细胞形成肿瘤。这些发现表明外泌体在癌症发生或疾病进展中发挥着关键作用,并为基于外泌体的诊断和治疗创造了新的机会。根据我们和其他研究的数据,越来越清楚的是,致癌病毒利用并修改宿主细胞外泌体途径,这些变化可能导致疾病。例如,感染人类肿瘤病毒 Epstein-Barr 病毒 (EBV) 的细胞会释放富含病毒产物的外泌体,例如主要病毒致癌基因潜伏膜蛋白 1 (LMP1) 和病毒编码的 miRNA。我们之前已经证明,LMP1 改变了受感染细胞释放的外泌体的货物,并且这些 LMP1 修饰的外泌体可以对邻近的未感染细胞发挥致癌信号传导功能。尽管 LMP1 修饰的外泌体的细胞间传播很重要,但人们对这种病毒蛋白实际上如何进入并操纵宿主外泌体途径知之甚少。这些研究的总体目标是确定 LMP1 驱动外泌体内容重组和改变外泌体功能的机制。我们假设 LMP1 外泌体运输通过改变内吞途径和膜微区来调节外泌体的成分和生物学特性。为了测试这一点,我们的目标是:1.) 研究 LMP1 改变外泌体成分的机制; 2.) 确定 LMP1 修饰的外泌体在细胞内通讯和细胞转化中的功能。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mesenchymal stem cell-derived extracellular vesicles ameliorate Alzheimer's disease-like phenotypes in a preclinical mouse model.
间充质干细胞衍生的细胞外囊泡在临床前小鼠模型中改善阿尔茨海默氏病的表型。
  • DOI:
    10.7150/thno.62069
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    12.4
  • 作者:
    Cone AS;Yuan X;Sun L;Duke LC;Vreones MP;Carrier AN;Kenyon SM;Carver SR;Benthem SD;Stimmell AC;Moseley SC;Hike D;Grant SC;Wilber AA;Olcese JM;Meckes DG Jr
  • 通讯作者:
    Meckes DG Jr
Multiplex protein profiling method for extracellular vesicle protein detection.
  • DOI:
    10.1038/s41598-021-92012-6
  • 发表时间:
    2021-06-14
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Sun L;Meckes DG Jr
  • 通讯作者:
    Meckes DG Jr
The Epstein-Barr virus LMP1 interactome: biological implications and therapeutic targets.
  • DOI:
    10.2217/fvl-2018-0120
  • 发表时间:
    2018-12
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Cheerathodi MR;Meckes DG Jr
  • 通讯作者:
    Meckes DG Jr
Methodological Approaches to Study Extracellular Vesicle miRNAs in Epstein⁻Barr Virus-Associated Cancers.
Differential Effects of Extracellular Vesicles of Lineage-Specific Human Pluripotent Stem Cells on the Cellular Behaviors of Isogenic Cortical Spheroids
  • DOI:
    10.3390/cells8090993
  • 发表时间:
    2019-09-01
  • 期刊:
  • 影响因子:
    6
  • 作者:
    Marzano, Mark;Bejoy, Julie;Li, Yan
  • 通讯作者:
    Li, Yan
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David G Meckes其他文献

David G Meckes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David G Meckes', 18)}}的其他基金

Modulation of Host Cell Exosome Content and Function by EBV LMP1
EBV LMP1 对宿主细胞外泌体含量和功能的调节
  • 批准号:
    9238748
  • 财政年份:
    2016
  • 资助金额:
    $ 40.64万
  • 项目类别:
Modulation of Host Cell Exosome Content and Function by EBV LMP1
EBV LMP1 对宿主细胞外泌体含量和功能的调节
  • 批准号:
    9080680
  • 财政年份:
    2016
  • 资助金额:
    $ 40.64万
  • 项目类别:

相似海外基金

Histone H3.3-dependent transcriptional control and B cell differentiation
组蛋白 H3.3 依赖性转录控制和 B 细胞分化
  • 批准号:
    DP230102695
  • 财政年份:
    2023
  • 资助金额:
    $ 40.64万
  • 项目类别:
    Discovery Projects
FCRL1 in B cell differentiation
FCRL1 在 B 细胞分化中的作用
  • 批准号:
    10730705
  • 财政年份:
    2023
  • 资助金额:
    $ 40.64万
  • 项目类别:
Mechanisms of pathogenic B cell differentiation associated with genetic risk for systemic lupus erythematosus.
与系统性红斑狼疮遗传风险相关的致病性 B 细胞分化机制。
  • 批准号:
    21H02960
  • 财政年份:
    2021
  • 资助金额:
    $ 40.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Roles for S-adenosylmethionine in B cell differentiation and activation
S-腺苷甲硫氨酸在 B 细胞分化和激活中的作用
  • 批准号:
    21K20770
  • 财政年份:
    2021
  • 资助金额:
    $ 40.64万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
An enhanced mitochondrial function via glutaminolysis in human B cell differentiation: a potential therapeutic target for type 1 diabetes mellitus
通过人类 B 细胞分化中的谷氨酰胺分解增强线粒体功能:1 型糖尿病的潜在治疗靶点
  • 批准号:
    20K17524
  • 财政年份:
    2020
  • 资助金额:
    $ 40.64万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
B cell differentiation in the germinal center reaction and the resulting memory B cell compartment in humans
人类生发中心反应中的 B 细胞分化以及由此产生的记忆 B 细胞区室
  • 批准号:
    418103381
  • 财政年份:
    2019
  • 资助金额:
    $ 40.64万
  • 项目类别:
    Research Grants
Mechanism of human B cell differentiation via amino-acid metabolism -Development of novel therapy for systemic lupus erythematosus-
人类B细胞通过氨基酸代谢分化的机制 -系统性红斑狼疮新疗法的开发-
  • 批准号:
    19K08900
  • 财政年份:
    2019
  • 资助金额:
    $ 40.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Epigenetic Regulation of Memory B Cell Differentiation and Reactivation
记忆 B 细胞分化和再激活的表观遗传调控
  • 批准号:
    9761825
  • 财政年份:
    2018
  • 资助金额:
    $ 40.64万
  • 项目类别:
Orchestration of memory B cell differentiation controlled by the regulation of IRF4 protein degradation
IRF4 蛋白降解调节控制记忆 B 细胞分化
  • 批准号:
    16K19026
  • 财政年份:
    2016
  • 资助金额:
    $ 40.64万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Elucidation of the mechanism for regulatory B cell differentiation by nephronectin and establishment of a novel therapeutic strategy for autoimmune diseases
阐明肾连接素调节B细胞分化的机制并建立自身免疫性疾病的新治疗策略
  • 批准号:
    16K08221
  • 财政年份:
    2016
  • 资助金额:
    $ 40.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了